Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Gabapentin is not a scheduled controlled substance. Gabapentin closely resembles pregabalin, a Schedule V controlled substance, in its chemical structure and pharmaceological activity. Gabapentin is a prescription medication approved by the Federal Food and Drug Administration for the treatment of neuropathic pain and epileptic disorders. While gabapentin is not a Federal Schedule V Controlled Substance, these recent actions taken by individual states should alert pharmacists about poten- tial risks related to the drug and high- light the possible need for additional patient counseling in some cases. The Controlled Substance Board and the Prescription Drug Monitoring Program (PDMP) staff has received requests by health care practitioners and law enforcement to have gabapentin included in the PDMP. Prescribers have indicated it is beneficial to be aware of a patient having a prescription for Gabapentin prior to prescribing an opioid because when combined with opioids there is an increase The Wisconsin Enhanced Prescription Drug Monitoring Program (ePDMP) is a tool to help combat the prescription drug abuse epidemic in Wisconsin. It provides valuable information about monitored prescription drugs that are dispensed to aid healthcare professionals in their prescribing and dispensing decisions. Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial 2015 Wisconsin Act 269 granted authority to the Board of Nursing to issue guidelines regarding best practices in prescribing controlled substances, as defined in s. 961.01 (4), Stats., for persons credentialed by the Board of Nursing who are authorized to prescribe controlled substances. Special use authorization. Drug disposal programs. Controlled substances therapeutic research. Controlled substances board duties relating to diversion control and pre-vention, compliance with controlled substances law and advice and assistance. Law enforcement duty. Prescriptions. Prescription drug monitoring program. The number of states placing gabapentin on the controlled substance list or in their required monitoring program is growing and three more states are debating whether to add gabapentin as a controlled substance or to their mandated reporting programs (DE, NY, and WI). Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. Gabapentin is a non controlled substance. Gabapentin does show characteristics of various medications associated with misuse and addiction such as benzodiazepines. It is highly sought after for use in potentiating opioids. When combined with opioids, the risk of respiratory depression and opioid-related mortality increases significantly. Wisconsin drug laws state that illegal possession of or possession with an intent to distribute prescription drugs such as Gabapentin could result in a Class H felony, which is a fine of up to $10,000, a prison term up to 6 years or both, but the specific penalties and classifications depend up the circumstances. Drug FAQ CONTROLLED SUBSTANCES – QUICK REFERENCE FOR SCHEDULE Wisconsin Department of Health Services / Division of Quality Assurance P-01807 (06/2023) This list is not meant to be all-inclusive but should assist in classifying a medication as a controlled substance along with its specific schedule. Many of these products come in multiple generics. As of May 6, 2025, in addition to any controlled substance identified in Schedule II, III, IV and V of the federal controlled substances act the Wisconsin CSB has also identified Gabapentin as having substantial potential for abuse. Avoid alcohol use during gabapentin treatment. Avoid other central nervous system depressants, including drugs that make you sleepy or dizzy. Future of gabapentin regulation As of June 2024, gabapentin remains a non-controlled substance under the U.S. federal government. Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. The Controlled Substances Board reviews ePDMP reports and refers potentially suspicious or critically dangerous conduct or practices of a pharmacy, pharmacist, or practitioner to relevant licensing boards. The Controlled Substances Board received information from those testifying at several law enforcement hearings held pursuant to 2017 Executive Order 228 and the Milwaukee Medical Examininers Office regarding the increase of the presence of gabapentin in overdose cases. The Controlled Substances Board reviewed research of the affects of gabapentin. Wisconsin Administrative Code Controlled Substances Board Chapter CSB 2 - Additions to Schedules in SS. 961.14, 961.16, 961.18, 961.20 and 961.22, Stats. Chapter CSB 3 - Special Use Authorization Chapter CSB 4 - Prescription Drug Monitoring Program Wisconsin Statutes Chapter 15 - Structure of the executive branch Chapter 440 - Department of safety and professional services Chapter 961 Gabapentin is a non controlled substance. Gabapentin does show characteristics of various medications associated with misuse and addiction such as benzodiazepines. It is highly sought after for use in potentiating opioids. When combined with opioids, the risk of respiratory depression and opioid-related mortality increases significantly. 961.36 Controlled substances board duties relating to diversion control and prevention, compliance with controlled substances law and advice and assistance.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |